S Fröhling Selected Research

S Fröhling Research Topics

Disease

14	Neoplasms (Cancer) 06/2022 - 04/2001
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 04/2001
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 02/2021
2	Skin Neoplasms (Skin Cancer) 12/2021 - 01/2017
2	Chromosome Aberrations (Chromosome Abnormalities) 06/2015 - 04/2015
2	Pathologic Complete Response 11/2004 - 08/2003
1	Eccrine Porocarcinoma 12/2021
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Adenocarcinoma of Lung 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021
1	Cardiotoxicity 11/2020
1	Aggressive Fibromatosis (Desmoid) 06/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Gallbladder Neoplasms (Gallbladder Cancer) 05/2016
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2016
1	Acute Promyelocytic Leukemia 06/2005
1	Lymphopenia (Lymphocytopenia) 03/2004
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2004
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2004
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2001
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2001

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2001
2	Biological ProductsIBA 01/2022 - 02/2021
2	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2019
2	Messenger RNA (mRNA)IBA 10/2021 - 03/2004
2	AntibodiesIBA 10/2017 - 05/2016
2	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2005 - 08/2003
2	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2005 - 08/2003
1	PlatinumIBA 06/2022
1	Delta CateninIBA 12/2021
1	B7-H1 AntigenIBA 12/2021
1	2-methylphenyl cinnamateIBA 12/2021
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2021
1	erucylphosphocholineIBA 12/2021
1	Phosphotransferases (Kinase)IBA 12/2021
1	Protons (Proton)IBA 02/2021
1	CarbonIBA 02/2021
1	IonsIBA 02/2021
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 10/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2017
1	RNA (Ribonucleic Acid)IBA 10/2017
1	regorafenibIBA 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	130-nm albumin-bound paclitaxelIBA 05/2016
1	Cisplatin (Platino)FDA LinkGeneric 05/2016
1	Gemcitabine FDA Link 05/2016
1	Trastuzumab (Herceptin)FDA Link 05/2016
1	pertuzumabIBA 05/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2016
1	NucleotidesIBA 06/2015
1	TOR Serine-Threonine KinasesIBA 04/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2015
1	MicroRNAs (MicroRNA)IBA 02/2013
1	N 30IBA 11/2004
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2004
1	Insulin (Novolin)FDA Link 03/2004
1	Etoposide (VP 16)FDA LinkGeneric 08/2003
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 08/2003
1	Origin Recognition ComplexIBA 04/2001

Therapy/Procedure

12	Therapeutics 12/2021 - 08/2003
2	Drug Therapy (Chemotherapy) 06/2022 - 11/2004
1	Precision Medicine 01/2022
1	Heavy Ion Radiotherapy 02/2021
1	Radiotherapy 06/2020
1	Investigational Therapies (Experimental Therapy) 10/2017
1	Salvage Therapy 01/2017